Tight control of RA ‘rapidly conquers fatigue’
An early treat-to-target strategy should improve fatigue as it seems to go hand-in-hand with disease activity, researchers say.
Most patients with early rheumatoid arthritis (RA) undergoing treat-to-target therapy can expect to see a reduction in fatigue levels after just three months, a study shows.
The findings suggest a close relationship between levels of disease activity and patient-reported fatigue, although this did not hold for all patients, the Norwegian researchers say.
